Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy

VV Maldonado, NH Patel, EE Smith, CL Barnes… - Journal of biological …, 2023 - Springer
Mesenchymal stem/stromal cells (MSCs) have been carefully examined to have tremendous
potential in regenerative medicine. With their immunomodulatory and regenerative …

Mesenchymal stromal cells and their secretome: new therapeutic perspectives for skeletal muscle regeneration

M Sandonà, L Di Pietro, F Esposito… - … in Bioengineering and …, 2021 - frontiersin.org
Mesenchymal stromal cells (MSCs) are multipotent cells found in different tissues: bone
marrow, peripheral blood, adipose tissues, skeletal muscle, perinatal tissues, and dental …

Current and emerging treatment strategies for Duchenne muscular dystrophy

JK Mah - Neuropsychiatric disease and treatment, 2016 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in
childhood. It is caused by mutations of the DMD gene, leading to progressive muscle …

Stem cell therapy for muscular dystrophies

S Biressi, A Filareto, TA Rando - The Journal of Clinical Investigation, 2020 - jci.org
Muscular dystrophies are a heterogeneous group of genetic diseases, characterized by
progressive degeneration of skeletal and cardiac muscle. Despite the intense investigation …

Development of electrospun chitosan-polyethylene oxide/fibrinogen biocomposite for potential wound healing applications

TT Yuan, AM DiGeorge Foushee, MC Johnson… - Nanoscale research …, 2018 - Springer
Normal wound healing is a highly complex process that requires the interplay of various
growth factors and cell types. Despite advancements in biomaterials, only a few bioactive …

[PDF][PDF] Nanoparticles in wound healing; from hope to promise, from promise to routine

N Naderi, D Karponis, A Mosahebi, AM Seifalian - Front. Biosci, 2018 - article.imrpress.com
Introduction 2. Nanoparticles in wound healing 2.1. Nanoparticles with antimicrobial
properties 2.1. 1. Antimicrobial activity of silver nanoparticles (AgNP) 2.1. 2. AgNPs …

The therapeutic potential of IGF-I in skeletal muscle repair

YH Song, JL Song, P Delafontaine… - Trends in Endocrinology & …, 2013 - cell.com
Skeletal muscle loss due to aging, motor-neuron degeneration, cancer, heart failure, and
ischemia is a serious condition for which currently there is no effective treatment. Insulin-like …

Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms

CO Rodini, PBG da Silva, AF Assoni… - …, 2018 - pmc.ncbi.nlm.nih.gov
Mesenchymal stem cells (MSC) display tumor tropism and have been addressed as vehicles
for delivery of anti-cancer agents. As cellular components of the tumor microenvironment …

Fibrin as a delivery system in wound healing tissue engineering applications

D Whelan, NM Caplice, AJP Clover - Journal of Controlled Release, 2014 - Elsevier
Fibrin is formed in the body upon initiation of the clotting cascade and is produced
commercially for use as a tissue sealant and hemostasis device during surgical procedures …

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy

Q Nguyen, KRQ Lim, T Yokota - The application of clinical genetics, 2019 - Taylor & Francis
Congenital muscular dystrophy (CMD) is a class of severe early-onset muscular dystrophies
affecting skeletal/cardiac muscles as well as the central nervous system (CNS). Laminin-α2 …